对《意大利多发性硬化症登记册》的勘误
Correction to: The Italian multiple sclerosis register.
作者信息
Trojano Maria, Bergamaschi Roberto, Amato Maria Pia, Comi Giancarlo, Ghezzi Angelo, Lepore Vito, Marrosu Maria Giovanna, Mosconi Paola, Patti Francesco, Ponzio Michela, Zaratin Paola, Battaglia Mario Alberto
机构信息
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, "Aldo Moro" Policlinico Italy, Piazza Umberto I, Bari, Bari, Italy.
Multiple Sclerosis Center, IRCCS Mondino Foundation, Pavia, Italy.
出版信息
Neurol Sci. 2019 Apr;40(4):907. doi: 10.1007/s10072-019-03772-z.
Abstract
Unfortunately in the original publication, the affiliation of the author Maria Pia Amato was incorrect. The author inadvertently missed out to include her second affiliation.
摘要
遗憾的是，在原出版物中，作者玛丽亚·皮娅·阿马托的单位信息有误。作者不小心遗漏了她的第二个单位信息。
相似文献
1
Correction to: The Italian multiple sclerosis register.对《意大利多发性硬化症登记册》的勘误
Neurol Sci. 2019 Apr;40(4):907. doi: 10.1007/s10072-019-03772-z.
2
Correction to: Transsphenoidal surgery for pituitary adenomas: early results from a single center.
Hormones (Athens). 2019 Mar;18(1):115. doi: 10.1007/s42000-019-00091-y.
3
Correction to: Tracking cognitive impairment in multiple sclerosis using the Brain on Track test: a validation study.
Neurol Sci. 2020 Jan;41(1):193. doi: 10.1007/s10072-019-04130-9.
4
Correction to: Cognitive assessment in multiple sclerosis-an Italian consensus.对《多发性硬化症的认知评估——意大利共识》的勘误
Neurol Sci. 2019 May;40(5):1097. doi: 10.1007/s10072-019-03852-0.
5
Author Correction: Progress in multiple sclerosis - from diagnosis to therapy.作者更正：多发性硬化症的进展——从诊断到治疗
Nat Rev Neurol. 2019 May;15(5):306. doi: 10.1038/s41582-019-0179-z.
6
Correction to: Central nervous system (CNS) neuroblastoma. A case-based update.
Childs Nerv Syst. 2019 May;35(5):899. doi: 10.1007/s00381-019-04100-8.
7
Correction to: Posterior cranial fossa and spinal local infections.
Childs Nerv Syst. 2019 May;35(5):901. doi: 10.1007/s00381-019-04101-7.
8
Correction to: A case series of lateral opening wedge high tibial osteotomy for valgus malalignment.《外翻畸形的外侧开放楔形高位胫骨截骨术病例系列》勘误
Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):2215. doi: 10.1007/s00167-017-4751-z.
9
Correction to: Effluent composition prediction of a two-stage anaerobic digestion process: machine learning and stoichiometry techniques.
Environ Sci Pollut Res Int. 2019 Feb;26(5):5234. doi: 10.1007/s11356-018-4048-x.
10
Correction to: Losing to Gain: The Effects of a Healthy Lifestyle Intervention on the Physical and Psychosocial Well-being of Clients in a Community-based Mental Health Setting.
Community Ment Health J. 2019 Aug;55(6):1071. doi: 10.1007/s10597-019-00397-6.
引用本文的文献
1
The arisal of data spaces: why I am excited and worried.数据空间的出现：我感到兴奋和担忧的原因。
Front Immunol. 2024 Oct 22;15:1461361. doi: 10.3389/fimmu.2024.1461361. eCollection 2024.
2
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.在儿童、成人和晚发性多发性硬化症中，与复发活动状态无关的残疾进展轨迹有所不同。
J Neurol. 2024 Oct;271(10):6782-6790. doi: 10.1007/s00415-024-12638-0. Epub 2024 Aug 23.
3
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in Italy.在意大利，特立氟胺在初治与复发缓解型多发性硬化症经治患者中的成本-效用分析。
Neurol Sci. 2022 Aug;43(8):4933-4944. doi: 10.1007/s10072-022-06022-x. Epub 2022 Apr 14.
4
Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience.复发型多发性硬化患者失业状况的预测因素：一项单中心经验。
Neurol Sci. 2022 Jul;43(7):4387-4392. doi: 10.1007/s10072-022-06029-4. Epub 2022 Mar 23.
5
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database.多发性硬化症用药的药物不良反应：来自意大利药物警戒数据库的分析
Front Pharmacol. 2022 Feb 23;13:808370. doi: 10.3389/fphar.2022.808370. eCollection 2022.
6
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.西尼莫德治疗意大利多发性硬化症继发进展期的成本效果和预算影响分析。
PLoS One. 2022 Mar 8;17(3):e0264123. doi: 10.1371/journal.pone.0264123. eCollection 2022.
7
Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health.Δ-9-四氢大麻酚/大麻二酚治疗多发性硬化症：根据《国际功能、残疾和健康分类》对自主功能概况的影响
Eur J Case Rep Intern Med. 2021 Sep 6;8(9):002298. doi: 10.12890/2021_002298. eCollection 2021.
8
An "all-wheel drive" proposal to accelerate clinical research in common and rare neurological diseases.推进常见和罕见神经疾病临床研究的“全轮驱动”建议。
Neurol Sci. 2020 Apr;41(4):789-793. doi: 10.1007/s10072-019-04189-4. Epub 2019 Dec 19.
9
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.多发性硬化症中的认知障碍：环境和生活方式风险因素的探索性分析。
PLoS One. 2019 Oct 21;14(10):e0222929. doi: 10.1371/journal.pone.0222929. eCollection 2019.
Zotero 插件